| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/06/2004 | EP1414455A1 Isoquinoline inhibitors of p38 |
| 05/06/2004 | EP1414454A1 Paroxetine glycyrrhizinate |
| 05/06/2004 | EP1414451A1 Opioid agonist formulations with releasable and sequestered antagonist |
| 05/06/2004 | EP1414450A1 (pyridinyl and pyrimidyl)trienoic acid derivatives as retinoid x receptor modulators |
| 05/06/2004 | EP1414447A1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 05/06/2004 | EP1414446A1 Pramipexol as an anticonvulsive agent |
| 05/06/2004 | EP1414444A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 05/06/2004 | EP1414442A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
| 05/06/2004 | EP1414440A1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 05/06/2004 | EP1414439A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/06/2004 | EP1414437A2 Agent for protection of retinal neurons |
| 05/06/2004 | EP1414435A1 Crystalline composition containing escitalopram |
| 05/06/2004 | EP1414432A2 Methods of use for novel sulfur containing organic nitrate compounds |
| 05/06/2004 | EP1414428A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 05/06/2004 | EP1414427A2 Kavalactone compositions and methods of use |
| 05/06/2004 | EP1414426A1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| 05/06/2004 | EP1414424A1 Agent for treating the symptoms of dementia disorders containing an additional local anesthetic agent |
| 05/06/2004 | EP1414423A1 Agent for treating depressive disorders containing a local anesthetic agent |
| 05/06/2004 | EP1414418A1 Compositions and methods to prevent abuse of opioids |
| 05/06/2004 | EP1414416A2 Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery |
| 05/06/2004 | EP1414413A1 Compositions and methods to prevent abuse of opioids |
| 05/06/2004 | EP1414408A1 Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt |
| 05/06/2004 | EP1353665A4 Treatment of depression |
| 05/06/2004 | EP1305307B1 Indole derivatives useful for the treatment of cns disorders |
| 05/06/2004 | EP1268407B1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/06/2004 | EP1263753B1 Imidazol derivatives as raf kinase inhibitors |
| 05/06/2004 | EP1261602B1 Imidazol-2-carboxamide derivatives as raf kinase inhibitors |
| 05/06/2004 | EP1261600B1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 05/06/2004 | EP1257548B1 Benzofuran carboxamides and their therapeutic use |
| 05/06/2004 | EP1227714B1 Method for producing metabolites from plants cultivated in soil-less medium |
| 05/06/2004 | EP1222162B1 Novel ltb4-antagonist, method for the production thereof and its use as a medicament |
| 05/06/2004 | EP1206489B1 Orally active peptides that prevent cell damage and death |
| 05/06/2004 | EP1163237B1 Amide derivatives |
| 05/06/2004 | EP1060181B1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 05/06/2004 | EP0960106B1 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4) |
| 05/06/2004 | EP0792287B1 Peptide analogs of human myelin basic protein |
| 05/06/2004 | EP0776161B1 Use of a viral vector encoding a cytochrome p450 gene in combination with a chemotherapeutic agent for selectively destroying neoplastic cells |
| 05/06/2004 | CA2504272A1 Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators |
| 05/06/2004 | CA2503455A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/06/2004 | CA2503026A1 Antibody and utilization of the same |
| 05/06/2004 | CA2503015A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2004 | CA2502932A1 Triazole compounds for the treatment of dysmenorrhoea |
| 05/06/2004 | CA2502906A1 Spirocyclopropyl amides and acids and their therapeutic applications |
| 05/06/2004 | CA2502819A1 Inhibitors of glycogen synthase kinase 3 |
| 05/06/2004 | CA2502607A1 Method for treating erectile dysfunction and increasing libido in men |
| 05/06/2004 | CA2502432A1 Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors |
| 05/06/2004 | CA2502323A1 Cycloalkylamides and their therapeutic use as antiepileptic and anticonvulsant |
| 05/06/2004 | CA2502320A1 Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy |
| 05/06/2004 | CA2498215A1 Oxindole substituted piperazine derivatives |
| 05/05/2004 | CN1494588A Use of protein histidine phosphatase |
| 05/05/2004 | CN1494543A Substituted benzofuran-2-carboxamides derivatives |
| 05/05/2004 | CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 05/05/2004 | CN1494541A Heterocyclic inhibitors of ERK 2 and uses thereof |
| 05/05/2004 | CN1494532A New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 05/05/2004 | CN1494526A Inhibitor of monoamine uptake |
| 05/05/2004 | CN1494425A Carboxamide derivatives as therapeutic agents |
| 05/05/2004 | CN1494423A Benzimidazole derivatives as therapeutic agents |
| 05/05/2004 | CN1494422A Use of GABAA inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin E for treatment of cognitive disorders |
| 05/05/2004 | CN1493353A Chinese compound medicine for treating anhypnosis and its preparation metod |
| 05/05/2004 | CN1493346A Functional medical wine for treating various diseases |
| 05/05/2004 | CN1493328A Oral modicine for treating aphronesia |
| 05/05/2004 | CN1493324A Compound health protection liquid agent for external use and its preparation method |
| 05/05/2004 | CN1493319A Medicine composition for treating neurasthenia |
| 05/05/2004 | CN1493303A Extraction method of scorpion active protein liquid |
| 05/05/2004 | CN1493302A Rabbit skin containing bioactive substance and its use |
| 05/05/2004 | CN1493288A Hanfangchin A drip pill and its preparation method |
| 05/05/2004 | CN1493287A Shishan alkaloid drip pill and its preparation method |
| 05/05/2004 | CN1493283A Edalavon powder for ampoul injection having good stability and its preparation method |
| 05/05/2004 | CN1493275A Paeonol drip pill and its preparation method |
| 05/05/2004 | CN1493274A Vanillic aldehyde drip pill and its preparation method |
| 05/05/2004 | CN1148367C Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 05/05/2004 | CN1148357C Triazole derivative |
| 05/05/2004 | CN1148356C Benzosulfone derivatives |
| 05/05/2004 | CN1148351C Compound for curing vascular complication, its preparing method and treating use |
| 05/05/2004 | CN1148350C Novel VLA-4 inhibitor: oMePUPA-V |
| 05/05/2004 | CN1148226C Aqueous risperidone formulations |
| 05/05/2004 | CN1148215C Kidney benefiting belt |
| 05/05/2004 | CN1148198C Non-toxic cotton seed extractions and their extraction process ,medicinal composition and use as antianxiety agent and/or antidepressant |
| 05/05/2004 | CN1148193C Application of oligose treating stress brani injury |
| 05/05/2004 | CN1148186C Clonidine preparation |
| 05/05/2004 | CN1148185C Inhibitor for generation of 3-deoxyglucurone |
| 05/05/2004 | CN1148182C Application of tea polyphenol in preparing medicine to suppress beta-amyloid aggregation and fibroplasia |
| 05/04/2004 | US6730794 Substituted indolealkanoic acids |
| 05/04/2004 | US6730787 Viricides, immunostimulants, antitubercular, anticarcinogenic, antitumor, antidepressant, antichlamydial, and analgesic agents; psychological disorders |
| 05/04/2004 | US6730778 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 05/04/2004 | US6730706 Treatments using venlafaxine |
| 05/04/2004 | US6730696 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 05/04/2004 | US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors |
| 05/04/2004 | US6730692 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 05/04/2004 | US6730690 Delaying the onset or reducing the risk of developing atherosclerosis in a human patient comprising administering to said patient an effective amount of a compound of invention and an hmg-coa reductase inhibitor |
| 05/04/2004 | US6730681 Anxiolytic agents and anticonvulsants |
| 05/04/2004 | US6730677 Treating memory impairment; enhance excitatory synaptic activity in order to restore an imbalance between brain subregions, as in treatment of schizophrenia or schizophreniform behavior. |
| 05/04/2004 | US6730676 Central nervous system disorders; cognition activators |
| 05/04/2004 | US6730674 Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 05/04/2004 | US6730671 Compounds useful as reversible inhibitors of cathespin S |
| 05/04/2004 | US6730670 7-phenyl-benzo[b]thiophen amide derivatives |
| 05/04/2004 | US6730519 Method of preparing delta-9-tetrahydrocannabinol |
| 05/04/2004 | US6730505 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/04/2004 | US6730480 Sphingosine kinase enzyme |
| 05/04/2004 | US6730325 Multiparticulate modified release composition |